Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 36 | $6,319,422 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 19 Nov 2024 21:57 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 15 Nov 2024 | Sale | 8,761 | 27.694 | 242,627 | D |
| 19 Nov 2024 21:57 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 15 Nov 2024 | Sale | 300 | 28.823 | 8,647 | D |
| 08 Nov 2024 17:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 06 Nov 2024 | Sale | 10,000 | 35.189 | 351,890 | D |
| 01 Nov 2024 20:59 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 30 Oct 2024 | Sale | 4,515 | 32.526 | 146,855 | D |
| 01 Nov 2024 20:59 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 01 Nov 2024 | Sale | 15,485 | 32.619 | 505,105 | D |
| 16 Oct 2024 20:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 15 Oct 2024 | Sale | 14,525 | 30.496 | 442,954 | D |
| 16 Oct 2024 20:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 15 Oct 2024 | Sale | 300 | 30.927 | 9,278 | D |
| 16 Oct 2024 20:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 14 Oct 2024 | Sale | 6,136 | 30.029 | 184,258 | D |
| 23 Sep 2024 18:00 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 20 Sep 2024 | Sale | 5,500 | 27.652 | 152,086 | D |
| 18 Sep 2024 21:19 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 18 Sep 2024 | Sale | 3,871 | 27.56 | 106,685 | D |
| 18 Sep 2024 21:19 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 17 Sep 2024 | Sale | 2,037 | 27.548 | 56,115 | D |
| 18 Sep 2024 21:19 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 16 Sep 2024 | Sale | 2,485 | 27.515 | 68,375 | D |
| 13 Sep 2024 17:14 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 10 Sep 2024 | Sale | 637 | 26.18 | 16,677 | D |
| 05 Sep 2024 16:05 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 03 Sep 2024 | Sale | 949 | 27.614 | 26,206 | D |
| 28 Aug 2024 11:11 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 26 Aug 2024 | Sale | 5,200 | 27.514 | 143,073 | D |
| 28 Aug 2024 11:11 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 23 Aug 2024 | Sale | 8,851 | 27.527 | 243,641 | D |
| 13 Jun 2024 18:11 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 11 Jun 2024 | Sale | 2,825 | 22.641 | 63,961 | D |
| 15 Mar 2024 16:45 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 13 Mar 2024 | Sale | 723 | 28.33 | 20,483 | D |
| 06 Mar 2024 20:13 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 04 Mar 2024 | Sale | 20,646 | 35.49 | 732,727 | D |
| 18 Dec 2023 20:49 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 14 Dec 2023 | Sale | 597 | 20.76 | 12,394 | D |
| 25 Sep 2023 20:31 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 21 Sep 2023 | Sale | 2,200 | 48.3577 | 106,387 | D |
| 25 Sep 2023 20:31 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 21 Sep 2023 | Sale | 2,800 | 47.8461 | 133,969 | D |
| 25 Sep 2023 20:31 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 13 Sep 2023 | Sale | 617 | 50.34 | 31,060 | D |
| 30 Aug 2023 19:04 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 28 Aug 2023 | Sale | 500 | 50.67 | 25,335 | D |
| 30 Aug 2023 19:04 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 28 Aug 2023 | Sale | 5,245 | 49.9248 | 261,856 | D |
| 23 Jun 2023 20:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 23 Jun 2023 | Sale | 500 | 51.4087 | 25,704 | D |
| 23 Jun 2023 20:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 23 Jun 2023 | Sale | 10,500 | 50.7291 | 532,656 | D |
| 23 Jun 2023 20:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 22 Jun 2023 | Sale | 11,000 | 52.1759 | 573,935 | D |
| 23 Jun 2023 20:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 21 Jun 2023 | Sale | 11,349 | 52.2597 | 593,095 | D |
| 15 Jun 2023 21:29 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 13 Jun 2023 | Sale | 591 | 55.16 | 32,600 | D |
| 18 Jan 2023 17:30 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 13 Jan 2023 | Sale | 1,105 | 51.987 | 57,446 | D |
| 18 Jan 2023 17:30 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 13 Jan 2023 | Sale | 1,313 | 51.1784 | 67,197 | D |
| 18 Jan 2023 17:30 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 13 Jan 2023 | Sale | 1,534 | 49.8901 | 76,531 | D |
| 18 Jan 2023 17:30 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 13 Jan 2023 | Sale | 1,048 | 49.1187 | 51,476 | D |
| 13 Dec 2022 20:24 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 12 Dec 2022 | Sale | 402 | 43.77 | 17,596 | D |
| 13 Dec 2022 20:24 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 12 Dec 2022 | Sale | 4,598 | 43.18 | 198,542 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)